Building on Our Scientific Legacy to Deliver Firsts for Patients
We are committed to identifying unmet needs and harnessing the full potential of science to treat challenging human diseases
Meet Shionogi Canada Inc. (formerly Tanabe Pharma Canada)
Shionogi strives constantly to supply the best possible medicine to protect the health and wellbeing of the patients we serve. Since 1878, we have been committed to our mission of developing new treatments to help improve the lives of patients worldwide.
Following the acquisition of Tanabe Pharma Canada (TPC), we are now the proud providers of RADICAVA® in Canada.
Please note that the availability and supply chain of RADICAVA® Oral Suspension in Canada as well as the patient support program (PSP) will remain unchanged.
Shionogi Canada Inc. looks forward to continuing TPC’s commitment to the ALS community.
If you require additional information, please contact SI-CA@innomar-strategies.com or 1-833-211-6878.
